LivaNova (LIVN) Gross Margin Growth (3y) (2019 - 2026)
LivaNova (LIVN) Gross Margin Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.91 Bn | 193.31 Bn | 7.27 Bn | 264.00 |
| 2 | Stryker | 127.59 Bn | 124.11 Bn | 4.50 Bn | 459.00 |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 21.00 |
| 4 | Boston Scientific | 73.24 Bn | 72.70 Bn | 3.85 Bn | 8.00 |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | -316.00 |
| 6 | Dexcom | 34.38 Bn | 32.44 Bn | 830.00 Mn | 73.00 |
| 7 | GE HealthCare Technologies | 33.96 Bn | 31.85 Bn | 2.18 Bn | 90.00 |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -3,577.00 |
| 9 | Steris | 23.08 Bn | 22.60 Bn | 684.20 Mn | 113.00 |
| 10 | LivaNova | 4.29 Bn | 3.77 Bn | 273.67 Mn | 24.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 24.00 |
| Mar 31, 2026 | 120.00 |
| Dec 31, 2025 | -33.00 |
| Sep 30, 2025 | 78.00 |
| Jun 30, 2025 | -474.00 |
| Mar 31, 2025 | -188.00 |
| Dec 31, 2024 | -806.00 |
| Sep 30, 2024 | 287.00 |
| Jun 30, 2024 | 231.00 |
| Mar 31, 2024 | 291.00 |
| Dec 31, 2023 | -557.00 |
| Sep 30, 2023 | 906.00 |
| Jun 30, 2023 | 672.00 |
| Mar 31, 2023 | -211.00 |
| Dec 31, 2022 | 677.00 |
| Sep 30, 2022 | -27.00 |
| Jun 30, 2022 | -43.00 |
| Mar 31, 2022 | 373.00 |
| Dec 31, 2021 | 511.00 |
| Sep 30, 2021 | 253.00 |